| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



From the Unité de Mycologie Moléculaire,* CNRS FRE2948, Institut Pasteur, Paris; the INSERM EMI 0011 Université Paris 12 - Faculté de Médecine de Créteil and Département de Pathologie,
Hôpital Henri Mondor, Créteil; the Service dAnatomie Pathologique,
Hôpital Sainte Anne, Paris; and the Service de Maladies Infectieuses et Tropicales,
Hôpital Necker, Paris, France
Cryptococcus neoformans is a yeast responsible for disseminated meningoencephalitis in patients with cellular immune defects. The major virulence factor is the polysaccharide capsule. We took advantage of a relevant murine model of disseminated meningoencephalitis to study the early events associated with blood-brain barrier (BBB) crossing. Mice were sacrificed at 1, 6, 24, and 48 hours post-intravenous inoculation, and classical histology, electron microscopy, and double immunofluorescence were used to study tissues and yeasts. Crossing of the BBB occurred early after inoculation, did not involve the choroid plexus but instead occurred at the level of the cortical capillaries, and caused early and severe damage to the structure of the microvessels. Seeding of the leptomeninges was not the primary event but occurred secondary to leakage of cortical pseudocysts. Organ invasion was associated with changes in cryptococcal capsule structure and cell size, which differed in terms of magnitude and kinetics, depending on both the organs involved, and potentially, on the bed structure of the local capillary. The rapid changes in capsule structure could contribute to inability of the host immune response to control cryptococcal infection in extrapulmonary spaces.
This article has been cited by other articles:
![]() |
K. Vu, B. Weksler, I. Romero, P.-O. Couraud, and A. Gelli Immortalized Human Brain Endothelial Cell Line HCMEC/D3 as a Model of the Blood-Brain Barrier Facilitates In Vitro Studies of Central Nervous System Infection by Cryptococcus neoformans Eukaryot. Cell, November 1, 2009; 8(11): 1803 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Price, D. M. Murdoch, U. Agarwal, S. R. Lewin, J. H. Elliott, and M. A. French Immune Restoration Diseases Reflect Diverse Immunopathological Mechanisms Clin. Microbiol. Rev., October 1, 2009; 22(4): 651 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Frases, B. Pontes, L. Nimrichter, N. B. Viana, M. L. Rodrigues, and A. Casadevall Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules PNAS, January 27, 2009; 106(4): 1228 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Charlier, K. Nielsen, S. Daou, M. Brigitte, F. Chretien, and F. Dromer Evidence of a Role for Monocytes in Dissemination and Brain Invasion by Cryptococcus neoformans Infect. Immun., January 1, 2009; 77(1): 120 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zaragoza, M. Alvarez, A. Telzak, J. Rivera, and A. Casadevall The Relative Susceptibility of Mouse Strains to Pulmonary Cryptococcus neoformans Infection Is Associated with Pleiotropic Differences in the Immune Response Infect. Immun., June 1, 2007; 75(6): 2729 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Maxson, E. Dadachova, A. Casadevall, and O. Zaragoza Radial Mass Density, Charge, and Epitope Distribution in the Cryptococcus neoformans Capsule Eukaryot. Cell, January 1, 2007; 6(1): 95 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Shea, T. B. Kechichian, C. Luberto, and M. Del Poeta The Cryptococcal Enzyme Inositol Phosphosphingolipid-Phospholipase C Confers Resistance to the Antifungal Effects of Macrophages and Promotes Fungal Dissemination to the Central Nervous System Infect. Immun., October 1, 2006; 74(10): 5977 - 5988. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhou, R. A. Gault, T. R. Kozel, and W. J. Murphy Immunomodulation with CD40 Stimulation and Interleukin-2 Protects Mice from Disseminated Cryptococcosis Infect. Immun., April 1, 2006; 74(4): 2161 - 2168. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jain, L. Li, D. C. McFadden, U. Banarjee, X. Wang, E. Cook, and B. C. Fries Phenotypic Switching in a Cryptococcus neoformans Variety gattii Strain Is Associated with Changes in Virulence and Promotes Dissemination to the Central Nervous System Infect. Immun., February 1, 2006; 74(2): 896 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. McFadden, M. De Jesus, and A. Casadevall The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction J. Biol. Chem., January 27, 2006; 281(4): 1868 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zaragoza, C. Mihu, A. Casadevall, and J. D. Nosanchuk Effect of Amphotericin B on Capsule and Cell Size in Cryptococcus neoformans during Murine Infection Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4358 - 4361. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Martinez and A. Casadevall Specific Antibody Can Prevent Fungal Biofilm Formation and This Effect Correlates with Protective Efficacy Infect. Immun., October 1, 2005; 73(10): 6350 - 6362. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |